Literature DB >> 18796270

Preventive treatment of migraine: effect on weight.

William B Young1.   

Abstract

Weight gain is a common side effect of drugs used for headache prevention. Weight gain can adversely affect patient health, exacerbate comorbid metabolic disorders, and encourage noncompliance. Additionally, obesity may promote the chronification of episodic migraine. Few studies have looked specifically at the effect that headache medications have on weight. The practicing physician needs accurate information about important side effects, including weight gain, when selecting appropriate pharmacologic regimens. This article discusses the potential effects the more common headache medications have on weight.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18796270     DOI: 10.1007/s11916-008-0035-0

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  48 in total

Review 1.  Chronic daily headache.

Authors:  S D Silberstein; R B Lipton
Journal:  Curr Opin Neurol       Date:  2000-06       Impact factor: 5.710

2.  Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

Authors:  R B Lipton; W F Stewart; S Diamond; M L Diamond; M Reed
Journal:  Headache       Date:  2001 Jul-Aug       Impact factor: 5.887

3.  Obesity is a risk factor for transformed migraine but not chronic tension-type headache.

Authors:  Marcelo E Bigal; Richard B Lipton
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

4.  Effects of the antidepressant duloxetine on body weight: analyses of 10 clinical studies.

Authors:  Thomas N Wise; David G S Perahia; Beth A Pangallo; William G Losin; Curtis G Wiltse
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

5.  Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.

Authors:  G Bussone; H-C Diener; J Pfeil; S Schwalen
Journal:  Int J Clin Pract       Date:  2005-08       Impact factor: 2.503

6.  Enhancement of linear growth and weight gain by cyproheptadine in children with hypopituitarism receiving growth hormone therapy.

Authors:  P B Kaplowitz; S Jennings
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

7.  Safety of topiramate: adverse events and relationships to dosing.

Authors:  S D Shorvon
Journal:  Epilepsia       Date:  1996       Impact factor: 5.864

8.  Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.

Authors:  L F Fabre; F S Abuzzahab; M Amin; J L Claghorn; J Mendels; W M Petrie; S Dubé; J G Small
Journal:  Biol Psychiatry       Date:  1995-11-01       Impact factor: 13.382

Review 9.  Obesity, migraine, and chronic migraine: possible mechanisms of interaction.

Authors:  Marcelo E Bigal; Richard B Lipton; Philip R Holland; Peter J Goadsby
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

10.  Headache prevention outcome and body mass index.

Authors:  M E Bigal; M Gironda; S J Tepper; M Feleppa; A M Rapoport; F D Sheftell; R B Lipton
Journal:  Cephalalgia       Date:  2006-04       Impact factor: 6.292

View more
  5 in total

Review 1.  Obesity and chronic daily headache.

Authors:  Marcelo E Bigal; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2012-02

Review 2.  Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.

Authors:  Maria Gabriella Saracco; Gianni Allais; Vincenzo Tullo; Dario Zava; Deborha Pezzola; Giorgio Reggiardo; Stefano Omboni; Chiara Benedetto; Gennaro Bussone; Marco Aguggia
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 3.  Dietary considerations in migraine management: does a consistent diet improve migraine?

Authors:  Alan G Finkel; Juanita A Yerry; J Douglas Mann
Journal:  Curr Pain Headache Rep       Date:  2013-11

Review 4.  Migraine and body mass index categories: a systematic review and meta-analysis of observational studies.

Authors:  Raffaele Ornello; Patrizia Ripa; Francesca Pistoia; Diana Degan; Cindy Tiseo; Antonio Carolei; Simona Sacco
Journal:  J Headache Pain       Date:  2015-03-28       Impact factor: 7.277

5.  Metabolic syndrome and migraine.

Authors:  Amit Sachdev; Michael J Marmura
Journal:  Front Neurol       Date:  2012-11-19       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.